BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35171422)

  • 41. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells.
    Mishra R; Nathani S; Varshney R; Sircar D; Roy P
    Mol Biol Rep; 2020 Nov; 47(11):8499-8511. PubMed ID: 33074411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2.
    Ni L; Sun P; Ai M; Kong L; Xu R; Li J
    Phytomedicine; 2022 Sep; 104():154303. PubMed ID: 35802997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
    Bakhtiary Z; Barar J; Aghanejad A; Saei AA; Nemati E; Ezzati Nazhad Dolatabadi J; Omidi Y
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1244-1253. PubMed ID: 28323493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development, optimization and in vitro evaluation of oxaliplatin loaded nanoparticles in non-small cell lung cancer.
    Esim O; Bakirhan NK; Yildirim N; Sarper M; Savaser A; Ozkan SA; Ozkan Y
    Daru; 2020 Dec; 28(2):673-684. PubMed ID: 33089432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
    Dong YZ; Meng XM; Li GS
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
    Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
    Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
    Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Berberine Hydrochloride-Loaded Chitosan Nanoparticles Effectively Targets and Suppresses Human Nasopharyngeal Carcinoma.
    Wang Y; Wen B; Yu H; Ding D; Zhang J; Zhang Y; Zhao L; Zhang W
    J Biomed Nanotechnol; 2018 Aug; 14(8):1486-1495. PubMed ID: 29903063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
    Wang L; Qu J; Zhou L; Liao F; Wang J
    Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles.
    De Rubis G; Paudel KR; Allam VSRR; Malyla V; Subramaniyan V; Singh SK; Panth N; Gupta G; Hansbro PM; Chellappan DK; Dua K
    Pathol Res Pract; 2024 Jan; 253():154971. PubMed ID: 38029714
    [No Abstract]   [Full Text] [Related]  

  • 55. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 56. Eupafolin regulates non-small-cell lung cancer cell proliferation,migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway.
    Wang X; Huang M; Xie W; Ding Q; Wang T
    J Biosci; 2023; 48():. PubMed ID: 36695419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death.
    Peng PL; Kuo WH; Tseng HC; Chou FP
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):529-42. PubMed ID: 18207031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROS-mediated pyroptosis and autophagy.
    Luo D; Dai X; Tian H; Fan C; Xie H; Chen N; Wang J; Huang L; Wang H; Wang G; Zhang Y
    Phytomedicine; 2023 Jul; 116():154909. PubMed ID: 37269775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nano strategies for berberine delivery, a natural alkaloid of Berberis.
    Mirhadi E; Rezaee M; Malaekeh-Nikouei B
    Biomed Pharmacother; 2018 Aug; 104():465-473. PubMed ID: 29793179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mangiferin inhibits lipopolysaccharide-induced epithelial-mesenchymal transition (EMT) and enhances the expression of tumor suppressor gene PER1 in non-small cell lung cancer cells.
    Lin YS; Tsai KL; Chen JN; Wu CS
    Environ Toxicol; 2020 Oct; 35(10):1070-1081. PubMed ID: 32420661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.